SCHEMBL16561918

SCHEMBL16561918

Cc1c(CN(C)C)c(O)[nH]c(=O)c1C#N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UPP1 Q16831 5/20 1.00
KDM4E B2RXH2 7/20 0.46
ATM Q13315 2/20 0.46
ALDH1A1 P00352 5/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 2/20 0.39
GLA P06280 1/20 0.38
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
APOBEC3G Q9HC16 3/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
APOBEC3A P31941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16561956 0.85 UPP1 (0.74) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL11121714 0.82 UPP1 (0.69) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL6655303 0.81 UPP1 (0.68) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL6625526 0.79 UPP1 (0.66) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL8025123 0.78 UPP1 (0.64) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL5182348 0.78 UPP1 (0.64) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL16561913 0.76 UPP1 (1.00) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL8941878 0.76 UPP1 (0.61) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL8901518 0.76 UPP1 (0.61) UPP1KDM4EATMALDH1A1CYP2C9
SCHEMBL9114384 0.76 UPP1 (0.60) UPP1KDM4EATMALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9700547-B2 Use of 6-hydroxy-2-pyridones and derivatives thereof for preparing a pharmaceutical composition that acts by inhibiting the human uridine phosphorylase enzyme UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA, MANTENEDORA DA PUCRS (BR) 2017-07-11 US disclosed
EP-3042657-A1 USE OF 6-HYDROXY-2-PYRIDONES AND DERIVATIVES THEREOF FOR PREPARING A PHARMACEUTICAL COMPOSITION THAT ACTS BY INHIBITING THE HUMAN URIDINE PHOSPHORYLASE ENZYME UNIÃO BRASILEIRA DE EDUCAÇAO E ASSISTÊNCIA- MANTENEDORA DA PUCRS (BR) 2016-07-13 EP disclosed
US-20160193197-A1 USE OF 6-HYDROXY-2-PYRIDONES AND DERIVATIVES THEREOF FOR PREPARING A PHARMACEUTICAL COMPOSITION THAT ACTS BY INHIBITING THE HUMAN URIDINE PHOSPHORYLASE ENZYME UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA, MANTENEDORA DA PUCRS (BR) 2016-07-07 US disclosed
WO-2015031968-A1 USE OF 6-HYDROXY-2-PYRIDONES AND DERIVATIVES THEREOF FOR PREPARING A PHARMACEUTICAL COMPOSITION THAT ACTS BY INHIBITING THE HUMAN URIDINE PHOSPHORYLASE ENZYME UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA, MANTENEDORA DA PUCRS (BR) 2015-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160193197-A1 USE OF 6-HYDROXY-2-PYRIDONES AND DERIVATIVES THEREOF FOR PREPARING A PHARMACEUTICAL COMPOSITION THAT ACTS BY INHIBITING THE HUMAN URIDINE PHOSPHORYLASE ENZYME UPP1, PNP, TYMP UPP1 1/4885KDM4E 1417/4885ATM 3479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.